Methotrexate Locally Released from Poly(ε-Caprolactone) Implants: Inhibition of the Inflammatory Angiogenesis Response in a Murine Sponge Model and the Absence of Systemic Toxicity.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Pharmacy and Science

• Publication date

  2015-11-01

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.1002/jps.24569PMID 26178442
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Macrophage activation and its role in repair and pathology after spinal cord injury.

  2015cited by this paper
• [Effects of ozurdex on intraocular pressure. A real life clinical practice study].

  2014cited by this paper
• Targeting interleukin-6 in inflammatory autoimmune diseases and cancers.

  2014cited by this paper
• Antiangiogenic Effect of Methotrexate and PUVA on Psoriasis

  2013cited by this paper
• Old drugs, old problems: where do we stand in prediction of rheumatoid arthritis responsiveness to methotrexate and other synthetic DMARDs?

  2013cited by this paper
• Resveratrol ameliorates methotrexate-induced hepatotoxicity in rats via inhibition of lipid peroxidation

  2013cited by this paper
• Efficacy of methotrexate-loaded poly(ε-caprolactone) implants in Ehrlich solid tumor-bearing mice

  2013cited by this paper
• The protective effects of Prunus armeniaca L (apricot) against methotrexate-induced oxidative damage and apoptosis in rat kidney

  2012cited by this paper
• Toxicity of a Biodegradable Microneedle Implant Loaded with Methotrexate as a Sustained Release Device in Normal Rabbit Eye: A Pilot Study

  2011cited by this paper
• Local drug delivery system: inhibition of inflammatory angiogenesis in a murine sponge model by dexamethasone-loaded polyurethane implants.

  2011cited by this paper
• Inflammation and wound healing: the role of the macrophage

  2011cited by this paper
• Therapeutic efficacy of experimental rheumatoid arthritis with low-dose methotrexate by increasing partially CD4+CD25+ Treg cells and inducing Th1 to Th2 shift in both cells and cytokines.

  2010cited by this paper
• Extracellular matrix, inflammation, and the angiogenic response.

  2010cited by this paper
• Biodegradable Implants for Sustained Drug Release in the Eye

  2010cited by this paper
• Angiogenesis in rheumatoid arthritis

  2009cited by this paper
• Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization.

  2009cited by this paper
• Characterization and in vitro release of praziquantel from poly(epsilon-caprolactone) implants.

  2009cited by this paper
• Wound healing essentials: Let there be oxygen

  2009cited by this paper
• Mechanisms of wound healing responses in lupus‐prone New Zealand White mouse strain

  2008cited by this paper
• Tumor growth, angiogenesis and inflammation in mice lacking receptors for platelet activating factor (PAF).

  2007cited by this paper
• Novel dexamethasone-HPMA copolymer conjugate and its potential application in treatment of rheumatoid arthritis

  2007cited by this paper
• Understanding and managing methotrexate nephrotoxicity.

  2006cited by this paper
• PREVENTION OF EXPERIMENTAL PROLIFERATIVE VITREORETINOPATHY WITH A BIODEGRADABLE INTRAVITREAL DRUG DELIVERY SYSTEM OF ALL-TRANS RETINOIC ACID

  2006cited by this paper
• Methotrexate-induced pancytopenia: serious and under-reported? Our experience of 25 cases in 5 years.

  2005cited by this paper
• Inhibition of inflammatory angiogenesis by distant subcutaneous tumor in mice.

  2004cited by this paper
• Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis.

  2004cited by this paper
• The use of methotrexate in rheumatoid arthritis.

  2004cited by this paper
• Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis.

  2003cited by this paper
• Effects of methotrexate upon inflammatory parameters induced by carrageenan in the mouse model of pleurisy.

  2002cited by this paper
• Angiogenesis in rheumatoid arthritis

  2002cited by this paper
• In vivo gene transfer of an extracellular domain of platelet-derived growth factor beta receptor by the HVJ-liposome method ameliorates bleomycin-induced pulmonary fibrosis.

  1999cited by this paper
• In Vivo Gene Transfer of an Extracellular Domain of Platelet-Derived Growth Factor β Receptor by the HVJ-Liposome Method Ameliorates Bleomycin-Induced Pulmonary Fibrosis

  1999cited by this paper
• Methotrexate reduces inflammatory cell numbers, expression of monokines and of adhesion molecules in synovial tissue of patients with rheumatoid arthritis.

  1998cited by this paper
• Necrosis and apoptosis in acute renal failure.

  1998cited by this paper
• Methotrexate: pentose cycle and oxidative stress

  1998cited by this paper
• Methotrexate in rheumatoid arthritis: an update with focus on mechanisms involved in toxicity.

  1998cited by this paper
• A single intra-articular injection of liposomally conjugated methotrexate suppresses joint inflammation in rat antigen-induced arthritis.

  1996cited by this paper
• In vitro effects of methotrexate on polyamine levels in lymphocytes from rheumatoid arthritis patients.

  1996cited by this paper
• L-tryptophan contaminant "peak E" and interleukin-5 production from T cells.

  1991cited by this paper
• An in vivo quantitative angiogenesis model using tumor cells entrapped in alginate.

  1990cited by this paper
• An in vivo quantitative angiogenesis model using tumor cells entrapped in alginate.

  1990cited by this paper
• High-dose methotrexate: a critical reappraisal.

  1987cited by this paper
• Methotrexate-induced misincorporation of uracil into DNA.

  1980cited by this paper
• SPECTROPHOTOMETRIC STUDIES II. PREPARATIONS FROM WASHED BLOOD CELLS; NITRIC OXIDE HEMOGLOBIN AND SULFHEMOGLOBIN

  1935cited by this paper

• Crosslinked Gelatin‐Polycaprolactone Scaffolds: Balancing Biocompatibility and Inflammatory Response for Tissue Engineering Applications

  2026cites this paper
• Effect of low- and high-dose methotrexate on wound healing in rats

  2025cites this paper
• Baccharis dracunculifolia DC (“Alecrim do campo”) nanoemulsion fails to modulate inflammation in mice under a high-sodium diet

  2025cites this paper
• Unveiling the Future: Opportunities in Long-Acting Injectable Drug Development for Veterinary Care

  2025cites this paper
• Advances in local drug delivery technologies for improved rheumatoid arthritis therapy.

  2024cites this paper
• Application of the Sponge Model Implants in the Study of Vaccine Memory in Mice Previously Immunized with LBSap

  2024cites this paper
• Chinese Medicine as Supporting Therapy for Psoriasis: Past, Present, and Future

  2022cites this paper
• Local drug delivery systems for inflammatory diseases: Status quo, challenges, and opportunities.

  2020cites this paper
• Amphotericin B-Loaded Poly(lactic-co-glycolic acid) Nanofibers: An Alternative Therapy Scheme for Local Treatment of Vulvovaginal Candidiasis.

  2018cites this paper
• Tacrolimus delivered from polymeric implants suppressed inflammation and angiogenesis in vivo without inducing nephrotoxicity, hepatotoxicity, and myelosuppression.

  2018cites this paper
• Adding Functions to Biomaterial Surfaces through Protein Incorporation

  2016cites this paper